纳米粒子输送的 Alu RNA 辅助剂增强了疫苗的免疫性
Alexander J Kwiatkowski1, Jacob A Schulman2, Hayden M Pagendarm2
1Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.
ACS applied materials & interfaces
|August 28, 2025
概括
合成的 Alu RNA 在纳米颗粒中有效刺激 CD8+ T 细胞的反应,从而提供了一个有前途的新型疫苗辅助剂. 这种新型辅助剂在临床前模型中表现出抗瘤能力和增强免疫检查点阻塞功效.
科学领域:
- 免疫学
- 疫苗学
- 纳米技术
背景情况:
- 疫苗辅助剂对于增强适应性免疫力至关重要,但目前的选择往往导致CD8+ T细胞反应不足.
- 内生ALURNA被模式识别受体 (PRR) 识别,从而诱导无菌炎症.
- 需要新的,明确的辅助剂来提高疫苗的疗效,特别是对CD8+ T细胞介导的免疫.
研究的目的:
- 研究合成阿鲁RNA分子作为疫苗辅助剂的潜力.
- 开发一种纳米疫苗配方,以有效的细胞内输送和内体RNA逃逸.
- 评估AluRNA辅助纳米疫苗的免疫性和治疗效果.
主要方法:
- 合成的 Alu RNA 与模型抗原一起被封装成设计用于内体逃生的聚合物纳米粒子.
- 在实验室中刺激了呈抗原的细胞,并在免疫反应中评估了免疫反应.
- 在小鼠模型中评估了CD8+ T细胞反应,瘤保护和结合抗PD-1免疫检查点阻塞的疗效.
主要成果:
- 该AluRNA纳米疫苗配方激活了抗原呈现细胞,并引起了与PolyIC辅助剂相比较强大的CD8+T细胞反应.
- 在小鼠中使用阿鲁RNA辅助纳米疫苗对瘤产生保护作用.
- 这些纳米疫苗在已确定的瘤中表现出有效性,并增强了对抗PD-1 免疫检查点阻塞的反应.
结论:
- 在聚合物纳米颗粒中配制的未经编辑的 Alu RNA 作为有效的疫苗辅助剂.
- 这种纳米疫苗配方可刺激具有显著抗瘤功能的CD8+ T细胞反应.
- 在疫苗研发过程中,Alu RNA代表了一种对异质PolyIC辅助剂有潜在优势的测序替代品.
更多相关视频
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
2.0K
06:02Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
Published on: February 23, 2024
775
相关概念视频
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...